Evidence map›Paper›PMID 24598220›Full record

ReviewEpidemiology and infection2014

A review of invasive Haemophilus influenzae disease in the Indigenous populations of North America.

R S W Tsang, M G Bruce, M Lem, L Barreto, M Ulanova

Open access · bronzeAbstract readReview
In one paragraph

Review in Epidemiology and infection, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 56 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Microorganisms · 2024
    Article
  6. Article
  7. Invasive and Non-invasive ClinicalPathogens & immunity · 2024
    Article
  8. Epidemiology of invasiveInternational journal of circumpolar health · 2022
    Article
  9. Article
  10. Review
  11. InvasiveOpen forum infectious diseases · 2020
    Article
  12. Observational
  13. Current Epidemiology and Trends in Invasive Haemophilus influenzae Disease-United States, 2009-2015.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2018
    Article
  14. Article
  15. Review
  16. The emergingCanada communicable disease report = Releve des maladies transmissibles au Canada · 2017
    Article
  17. Article
  18. JMM case reports · 2016
    Article
  19. Article
  20. Simulating Immune Interference on the Effect of a Bivalent Glycoconjugate Vaccine against Haemophilus influenzae Serotypes "a" and "b".The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

R S W TsangNational Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB,Canada.
M G BruceArctic Investigations Program, Division of Preparedness and Emerging Infections, U.S. Centers for Disease Prevention and Control (CDC), Anchorage, AK,USA.
M LemFraser Health Authority, Abbotsford, BC,Canada.
L BarretoHuman Health Therapeutics Portfolio, National Research Council of Canada, Ottawa, ON,Canada.
M UlanovaMedical Sciences Division, Northern Ontario School of Medicine, Thunder Bay, ON,Canada.
Fraser Health · CANOSM University · CAPublic Health Agency of Canada · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Historically, the highest incidence rates of invasive Haemophilus influenzae disease in the world were found in North American and Australian Indigenous children. Although immunization against H. influenzae type b (Hib) led to a marked decrease in invasive Hib disease in countries where it was implemented, this disease has not been eliminated and its rates in Indigenous communities remain higher than in the general North American population. In this literature review, we examined the epidemiology of invasive H. influenzae disease in the pre-Hib vaccine era, effect of carriage on disease epidemiology, immune response to H. influenzae infection and Hib vaccination in Indigenous and Caucasian children, and the changing epidemiology after Hib conjugate vaccine has been in use for more than two decades in North America. We also explored reasons behind the continued high rates of invasive H. influenzae disease in Indigenous populations in North America. H. influenzae type a (Hia) has emerged as a significant cause of severe disease in North American Indigenous communities. More research is needed to define the genotypic diversity of Hia and the disease burden that it causes in order to determine if a Hia vaccine is required to protect the vulnerable populations.

Indexed as

Haemophilus InfectionsHaemophilus influenzaeHaemophilus VaccinesHumansIncidenceIndians, North AmericanHaemophilus Vaccines

Identifiers

PMID24598220
PMCPMC9151223
OpenAlexW2121414998

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.